Inactivated Polio Vaccine (IPV) : a strong candidate vaccine for achieving global polio eradication program
Shahzad, A.; Köhler, G.
Vaccine 27(39): 5293-5294
2009
ISSN/ISBN: 0264-410X PMID: 19638271 DOI: 10.1016/j.vaccine.2009.06.106Document Number: 251289
In this article, we will present an update about current status of inactivated poliovirus vaccine (IPV) and we will also discuss general concerns about inactivated polio vaccine (IPV) which are under discussion in scientific community about various aspects of IPV and at the end of this article, we will give our conclusions about possible universal use of IPV.
Document emailed within 0-6 h
Related Documents
Domingues, C.Magda.Allan.S.; de Fátima Pereira, S.; Cunha Marreiros, A.Carolina.; Menezes, N.; Flannery, B. 2014: Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program Journal of Infectious Diseases 210 Suppl. 1: S143-S151Chiba, Y.; Hara, M. 1997: Polio vaccine and polio eradication initiative--progress of polio eradication in China Uirusu 47(1): 15-23
Thompson, K.M.; Kalkowska, D.A.; Badizadegan, K. 2022: Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative Gates Open Research 6: 5
Rümke, H.C. 1993: Vaccination against polio. Inactivated polio vaccine used in the Netherlands and Burkina Faso Tropical and Geographical Medicine 45(5): 202-205
Ion-Nedelcu, N.; Crăciun, D.; Strebel, P.; Ciufecu, C. 1997: The use of inactivated polio vaccine to prevent polio paralysis associated with the vaccination of children living in orphanages Bacteriologia Virusologia Parazitologia Epidemiologia 42(4): 243-248
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
van den Ent, M.M.V.X.; Swift, R.D.; Anaokar, S.; Hegg, L.Anne.; Eggers, R.; Cochi, S.L. 2017: Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan Journal of Infectious Diseases 216(Suppl_1): S244-S249
van den Ent, M.M.V.X.; Swift, R.D.; Anaokar, S.; Hegg, L.Anne.; Eggers, R.; Cochi, S.L. 2017: Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan Journal of Infectious Diseases 216(Suppl_1): S244-S249
Sartori, A.M.C.; Vicentine, M.P.; Gryninger, L.íg.C.F.; Soárez, P.C.d.; Novaes, H.M.D. 2015: Polio inactivated vaccine costs into routine childhood immunization in Brazil Revista de Saude Publica 49: 8
Schoub, B.D. 2012: Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa Vaccine 30 Suppl. 3: C35-C37
Axelsson, P. 2004: The history of polio in Sweden - from infantile paralysis to polio vaccine Svensk Medicinhistorisk Tidskrift 8(1): 57-66
Larsson, B.; Litwin, J. 1980: Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production Developments in Biological Standardization 46: 241-247
Taffs, R.; Dragunsky, E.; Nomura, T.; Hioki, K.; Levenbook, I.; Fitzgerald, E. 1996: Importance of experiments in poliovirus-susceptible transgenic mice for evaluating current potency tests of inactivated polio vaccine (IPV) Developments in Biological Standardization 86: 345
Más Lago, P.; Díaz, J.; Díaz Gonzalez, M.; Goyenechea Hernández, A.; Barrio Olivera, J.; Fonseca Quintana, M.; Morier Díaz, L.; Sarmiento Pérez, L.; Palomera Puente, R. 2005: Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine Revista Cubana de Medicina Tropical 57(2): 111-119
Troy, S.B.; Musingwini, G.; Halpern, M.S.; Huang, C.; Stranix-Chibanda, L.; Kouiavskaia, D.; Shetty, A.K.; Chumakov, K.; Nathoo, K.; Maldonado, Y.A. 2013: Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants Journal of Infectious Diseases 208(4): 672-678
Cheng, H.Kock.; Rajadurai, V.S.; Amin, Z.; Sriram, B.; Yee, M.F.; Han, H.H.; Bock, H.L.; Safary, A. 2004: Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine Southeast Asian Journal of Tropical Medicine and Public Health 35(3): 685-692
2013: Global polio eradication: not there yet Lancet 381(9860): 1
2004: Global Polio Eradication Initiative Strategic Plan, 2004 MMWR. Morbidity and mortality weekly report 53(5): 107-108
Chambers, S.T.; Dickson, N. 2011: Global polio eradication: progress, but determination and vigilance still needed New Zealand Medical Journal 124(1337): 100-104
Weiss, W.M.; Choudhary, M.; Solomon, R. 2013: Performance and determinants of routine immunization coverage within the context of intensive polio eradication activities in Uttar Pradesh, India: Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP) Bmc International Health and Human Rights 13: 25